HTA Quarterly | Late Summer 2018

By Xcenda |

We examine the world's second largest pharmaceuticals market as Japan shifts from a traditional reimbursement assessment. We look at new therapies for Tardive Dyskinesea.  We also review Taiwan's Center for Drug Evaluation on its 10 year anniversary.

Heard on the Street

“Today I can provide noble Lords with the strongest possible reassurance on the UK’s commitment to implement the (Clinical Trial Regulation) CTR. If the CTR comes into force during the implementation period, as it is currently expected to do in March 2020, it will apply to the UK. If this opportunity does not come to pass, the Government will seek to bring into UK law all relevant parts of the EU regulation that are within the UK’s control.”

– Baroness Goldie, affirming the UK’s commitment to align as closely as possible with EU rules on clinical trials following Brexit.
UK Parliament- European Union (Withdrawal) Bill Debate Transcripts

HTA by the Numbers


HTA Decision Map

Find detailed information on product decisions in Australia, Canada, France, Germany, and the United Kingdom with our HTA Decision Map.
Map of Europe